BioengineeringbioRxiv
Targeting caveolae to pump bispecific antibody to TGF-β into diseased lungs enables ultra-low dose therapeutic efficacy
A. H. Kadam, K. Kandasamy, T. Buss…·J. E. Schnitzer
This paper develops a bispecific antibody that targets caveolae to deliver TGF-β inhibitors specifically to lungs, achieving ultra-low dose therapeutic efficacy in a rat model.
DOI 10.1371/journal.pone.0276462